Bafetinib
Bafetinib (INNO-406) is a potent and selective dual inhibitor of Bcr-Abl and Lyn kinases, with IC50 values of 5.8 nM and 19 nM, respectively. It shows minimal activity against c-Kit and PDGFR and is ineffective against the T315I mutant. This compound is used in research for chronic myeloid leukemia, demonstrating efficacy in both cellular and animal models of the disease.
Product Specifications
CAS Number
859212-16-1
Product Name Alternative
INNO 406, INNO406, INNO-406, Inhibitor, NS187, NS-187, NS 187, inhibit, mutations, Lyn, Abl, Autophagy, Apoptosis, Bafetinib, BcrAbl, Bcr-Abl, philadelphia chromosome-positive leukemias, Src
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Purity
94.16% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (5.72 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:120 mg/mL (208.11 mM) ; Ethanol:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CN (C) [C@H]1CCN (Cc2ccc (cc2C (F) (F) F) C (=O) Nc2ccc (C) c (Nc3nccc (n3) -c3cncnc3) c2) C1
Molecular Formula
C30H31F3N8O
Molecular Weight
576.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog